RESEARCH STUDY

40 mg anti-inflammatory-dose doxycycline for rosacea (phase III, 2007)

2007
RCT
537
High

One-line finding

Once-daily 40 mg doxycycline reduced rosacea bumps more than placebo, with side effects similar to placebo.

Plain-language summary

These two trials tested a low 40 mg daily dose of doxycycline in people with rosacea. The low dose meaningfully reduced inflammatory bumps compared with a dummy pill. Because the dose is too low to act as a full antibiotic, side effects were close to those of placebo. This work supported FDA approval of the 40 mg rosacea formulation (Oracea).

Citation

Read the study